Michael S Hearne Insider Trading $LJPC LA JOLLA PHARMACEUTICAL CO
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael S Hearne.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael S Hearne. Michael S Hearne is Chief Financial Officer in LA JOLLA PHARMACEUTICAL CO ($LJPC) and Chief Financial Officer in Odonate Therapeutics, Inc. ($ODT).
Michael S Hearne in LA JOLLA PHARMACEUTICAL CO
Trading Symbol: LJPCIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Michael S Hearne: Chief Financial Officer
Holdings: 3,934 shares
Current Value: $76,595
Latest Transaction: Jun 02 2021
$LJPC Market Capitalization: $355.22M
$LJPC Previous Close: $19.47
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Michael S Hearne in LA JOLLA PHARMACEUTICAL CO
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.30 | 169 | 727 | 169 | |
Jun 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.66 | 169 | 618 | 3,934 | 3.8 K to 3.9 K (+4.49 %) |
May 04 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.44 | 163 | 724 | 163 | |
May 04 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.77 | 163 | 615 | 3,572 | 3.4 K to 3.6 K (+4.78 %) |
Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.18 | 173 | 723 | 173 | |
Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.55 | 173 | 615 | 3,835 | 3.7 K to 3.8 K (+4.72 %) |
Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.18 | 173 | 723 | 173 | |
Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.55 | 173 | 615 | 3,835 | 3.7 K to 3.8 K (+4.72 %) |
Apr 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.24 | 172 | 729 | 172 | |
Apr 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.60 | 172 | 620 | 3,662 | 3.5 K to 3.7 K (+4.93 %) |
Mar 17 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 5.71 | 127 | 725 | 127 | |
Mar 17 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 4.85 | 127 | 616 | 3,490 | 3.4 K to 3.5 K (+3.78 %) |
Feb 18 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 6.71 | 535 | 3,590 | 535 | |
Feb 18 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 5.70 | 535 | 3,051 | 3,224 | 2.7 K to 3.2 K (+19.90 %) |
Feb 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 6.12 | 118 | 722 | 118 | |
Feb 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 5.20 | 118 | 614 | 2,689 | 2.6 K to 2.7 K (+4.59 %) |
Jan 20 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 5.35 | 136 | 728 | 136 | |
Jan 20 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 4.55 | 136 | 618 | 1,094 | 958 to 1.1 K (+14.20 %) |
Jan 05 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 3.88 | 171 | 663 | 171 | |
Jan 05 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.30 | 171 | 564 | 958 | 787 to 958 (+21.73 %) |
Jan 05 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 3.88 | 171 | 663 | 171 | |
Jan 05 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.30 | 171 | 564 | 958 | 787 to 958 (+21.73 %) |
Dec 16 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.50 | 147 | 662 | 147 | |
Dec 16 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.83 | 147 | 562 | 787 | 640 to 787 (+22.97 %) |
Dec 14 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.53 | 52,191 | 236,425 | 52,191 | |
Dec 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.97 | 134 | 666 | 134 | |
Dec 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 4.23 | 134 | 566 | 640 | 506 to 640 (+26.48 %) |
Nov 05 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 3.40 | 196 | 666 | 196 | |
Nov 05 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 2.89 | 196 | 566 | 365 | 169 to 365 (+115.98 %) |
Oct 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 3.91 | 169 | 661 | 169 | |
Oct 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.32 | 169 | 561 | 169 | 0 to 169 |
Oct 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 3.91 | 169 | 661 | 169 | |
Oct 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.32 | 169 | 561 | 169 | 0 to 169 |
Page: 1